CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Alvogen Pharma US, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Alvogen Pharma US, Inc.
10 Bloomfield Ave
Phone: 973-796-3400p:973-796-3400 Pine Brook, NJ  07058  United States Fax: 973-796-3439f:973-796-3439
Business Summary
Alvogen Pharma US, Inc. is a multinational, privately-owned pharmaceuticals company, focused on complex generic pharmaceutical products. The Company's lines of business include generic sales and marketing, product development, contract manufacturing and contract research. The Company's product portfolio consists of a broad range of molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology in addition to a portfolio of biosimilars and OTC products. Its product formulations include solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments, and injectables. The Company is a subsidiary of Alvogen Lux Holdings Sarl ("LuxCo"). It comprises the US generic pharmaceuticals and contract manufacturing operations of LuxCo. The Company is 40% owned by Aztiq SICAR investment fund and 60% owned by Al Maseera (a Saudi family-owned company), GMS Holdings (a Jordanian family-owned company) and AFI Partners.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes--YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Business Names
Business Name
Gralise®
Labormed

General Information
Fax Number: 973-796-3439
Email Address: info@alvogen.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, November 28, 2024